Abstract:Background CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). Methods To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. Findings In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Interpretation Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population. CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population.

Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility.

Nucleotide Excision Repair Gene ERCC1 19007T>C Polymorphism Contributes to Lung Cancer Susceptibility: A Meta-Analysis

Variants in CYP2J2 and CYP2C9 Contribute to Susceptibility of Lung Cancer

Stratification analysis reveal associations between CYP2B6 polymorphisms and lung cancer susceptibility in Chinese Han population

A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolizing Enzymes CYP2D6 and Susceptibility to Lung Cancer

CYP4F2 and CYP3A5 Gene Polymorphisms and Lung Cancer in Chinese Han Population

Association of CYP19A1 Polymorphism with Genetic Susceptibility to Lung Cancer in Chinese population:a case-control study

Synergistic Association of PTGS2 and CYP2E1 Genetic Polymorphisms with Lung Cancer Risk in Northeastern Chinese

CYP2A6, CYP1A1, and CYP2D6 Polymorphisms in Lung Cancer Patients from Central South China.

Polymorphisms Of Cyp, Gst And Xrcc1 And Risk Of Lung Cancer In A Chinese Population

Association between missense mutations of CYP2A13 gene and lung cancer susceptibility

Meta-analysis of the CYP 1 A 2-163 C > A Polymorphism and Lung Cancer Risk

Sheng-Qiong Deng1&*, Xian-Tao Zeng2&,

P0162 CYP1B1 Polymorphisms and Hepatocellular Cancer Risk in a Chinese Population

The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.

[Study on the Association Between Genetic Polymorphism of CYP2E1, GSTM1 and Susceptibility of Lung Cancer].

Impact of COL6A4P2 gene polymorphisms on the risk of lung cancer in a Chinese Han population

Single nucleotide polymorphysims of CYP2D6 gene G4268C and ERCC1 gene C8092A and their genetic susceptibility to lung cancer

C2CD4A/B Variants in the Predisposition of Lung Cancer in the Chinese Han Population

Genetic polymorphisms in CYP2B6 may be associated with lung cancer risk in the Chinese Han population

Relationship Between Genetic Polymorphism of CYP1A1 and Lung Cancer Genetic Susceptibility